Riverbridge Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,061
| Closed | -$319K | – | 175 |
|
|
2023
Q4 | $319K | Buy |
2,061
+21
| +1% | +$3.25K | ﹤0.01% | 168 |
|
|
2023
Q3 | $304K | Hold |
2,040
| – | – | ﹤0.01% | 168 |
|
|
2023
Q2 | $275K | Hold |
2,040
| – | – | ﹤0.01% | 170 |
|
|
2023
Q1 | $325K | Hold |
2,040
| – | – | ﹤0.01% | 166 |
|
|
2022
Q4 | $330K | Hold |
2,040
| – | – | 0.01% | 167 |
|
|
2022
Q3 | $274K | Hold |
2,040
| – | – | ﹤0.01% | 175 |
|
|
2022
Q2 | $312K | Hold |
2,040
| – | – | 0.01% | 172 |
|
|
2022
Q1 | $331K | Hold |
2,040
| – | – | ﹤0.01% | 146 |
|
|
2021
Q4 | $276K | Hold |
2,040
| – | – | ﹤0.01% | 157 |
|
|
2021
Q3 | $220K | Hold |
2,040
| – | – | ﹤0.01% | 151 |
|
|
2021
Q2 | $230K | Sell |
2,040
-60
| -3% | -$6.77K | ﹤0.01% | 153 |
|
|
2021
Q1 | $227K | Buy |
2,100
+60
| +3% | +$6.49K | ﹤0.01% | 150 |
|
|
2020
Q4 | $219K | Buy |
+2,040
| New | +$219K | ﹤0.01% | 147 |
|
|
2020
Q3 | – | Sell |
-2,140
| Closed | -$210K | – | 149 |
|
|
2020
Q2 | $210K | Buy |
+2,140
| New | +$210K | ﹤0.01% | 143 |
|